ID

25958

Description

Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant; ODM derived from: https://clinicaltrials.gov/show/NCT00434629

Lien

https://clinicaltrials.gov/show/NCT00434629

Mots-clés

  1. 02/10/2017 02/10/2017 -
  2. 04/10/2017 04/10/2017 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

2 octobre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility B-Cell Lymphoma NCT00434629

Eligibility B-Cell Lymphoma NCT00434629

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
cd20 positive b-cell lymphoma
Description

B-Cell Lymphoma CD20 antigen positive

Type de données

boolean

Alias
UMLS CUI [1,1]
C0079731
UMLS CUI [1,2]
C3888518
confirmed relapsed/refractory disease following autologous transplant
Description

Autologous hematopoietic stem cell transplant | Recurrent disease | Refractory Disease

Type de données

boolean

Alias
UMLS CUI [1]
C2193200
UMLS CUI [2]
C0277556
UMLS CUI [3]
C1514815
age ≤ 75 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
performance status 0 or 1
Description

Performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1518965
creatinine ≤ 1.5 or calculated creatinine clearance ≥ 60 ml/min
Description

Creatinine measurement, serum | Estimation of creatinine clearance by Cockcroft-Gault formula

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C2711451
total bilirubin, ast, and alt ≤ 1.5 x upper limit of normal (unless bilirubin due to gilbert's)
Description

Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Exception Bilirubin Due to Gilbert Disease

Type de données

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0005437
UMLS CUI [4,3]
C0678226
UMLS CUI [4,4]
C0017551
no active cns disease
Description

CNS disorder Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007682
UMLS CUI [1,2]
C0332197
no detectable bone marrow involvement by lymphoma on histopathologic bone marrow examination
Description

Lymphoma involves bone marrow Undetectable Bone Marrow Examination

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301440
UMLS CUI [1,2]
C3827727
UMLS CUI [1,3]
C0005957
bone marrow cellularity ≥ 15% on histopathologic bone marrow examination
Description

Bone marrow cellularity Percentage Bone Marrow Examination

Type de données

boolean

Alias
UMLS CUI [1,1]
C1561532
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C0005957
availability of adequate stored autologous stem cell product (≥ 2 x 106 cd34+
Description

Stem cell product Autologous CD34 positive Availability

Type de données

boolean

Alias
UMLS CUI [1,1]
C1706452
UMLS CUI [1,2]
C0439859
UMLS CUI [1,3]
C0882849
UMLS CUI [1,4]
C0470187
cells/kg)
Description

ID.11

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
active infection
Description

Communicable Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0009450
pregnant woman are excluded from the study
Description

Pregnancy

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
subjects not using contraceptives are excluded from the study
Description

Contraceptive methods Lacking

Type de données

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0332268
anc ≤ 1,500/μl and/or platelet count ≤ 100,000/μl
Description

Absolute neutrophil count | Platelet Count measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
life expectancy of ≤ 2 months
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
prior anti-b-cell radioimmunotherapy (e.g., zevalin or bexxar) [patients who have received prior anti-b-cell monoclonal antibody therapy (e.g., rituximab or epratuzumab) will not be excluded.]
Description

Radioimmunotherapy Against B cells | Zevalin | Bexxar | Monoclonal Antibody Therapy Against B cells allowed | Rituximab allowed | Epratuzumab allowed

Type de données

boolean

Alias
UMLS CUI [1,1]
C0085101
UMLS CUI [1,2]
C0521124
UMLS CUI [1,3]
C0004561
UMLS CUI [2]
C0919274
UMLS CUI [3]
C0919272
UMLS CUI [4,1]
C0279694
UMLS CUI [4,2]
C0521124
UMLS CUI [4,3]
C0004561
UMLS CUI [4,4]
C0683607
UMLS CUI [5,1]
C0393022
UMLS CUI [5,2]
C0683607
UMLS CUI [6,1]
C1120776
UMLS CUI [6,2]
C0683607
prior total body radiation therapy
Description

Total body radiation therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0948732
positive human anti-mouse antibody (hama) testing
Description

Human anti-mouse antibody test Positive

Type de données

boolean

Alias
UMLS CUI [1,1]
C1868744
UMLS CUI [1,2]
C1514241

Similar models

Eligibility B-Cell Lymphoma NCT00434629

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
B-Cell Lymphoma CD20 antigen positive
Item
cd20 positive b-cell lymphoma
boolean
C0079731 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
Autologous hematopoietic stem cell transplant | Recurrent disease | Refractory Disease
Item
confirmed relapsed/refractory disease following autologous transplant
boolean
C2193200 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
C1514815 (UMLS CUI [3])
Age
Item
age ≤ 75 years
boolean
C0001779 (UMLS CUI [1])
Performance status
Item
performance status 0 or 1
boolean
C1518965 (UMLS CUI [1])
Creatinine measurement, serum | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
creatinine ≤ 1.5 or calculated creatinine clearance ≥ 60 ml/min
boolean
C0201976 (UMLS CUI [1])
C2711451 (UMLS CUI [2])
Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Exception Bilirubin Due to Gilbert Disease
Item
total bilirubin, ast, and alt ≤ 1.5 x upper limit of normal (unless bilirubin due to gilbert's)
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C0005437 (UMLS CUI [4,2])
C0678226 (UMLS CUI [4,3])
C0017551 (UMLS CUI [4,4])
CNS disorder Absent
Item
no active cns disease
boolean
C0007682 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Lymphoma involves bone marrow Undetectable Bone Marrow Examination
Item
no detectable bone marrow involvement by lymphoma on histopathologic bone marrow examination
boolean
C1301440 (UMLS CUI [1,1])
C3827727 (UMLS CUI [1,2])
C0005957 (UMLS CUI [1,3])
Bone marrow cellularity Percentage Bone Marrow Examination
Item
bone marrow cellularity ≥ 15% on histopathologic bone marrow examination
boolean
C1561532 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0005957 (UMLS CUI [1,3])
Stem cell product Autologous CD34 positive Availability
Item
availability of adequate stored autologous stem cell product (≥ 2 x 106 cd34+
boolean
C1706452 (UMLS CUI [1,1])
C0439859 (UMLS CUI [1,2])
C0882849 (UMLS CUI [1,3])
C0470187 (UMLS CUI [1,4])
ID.11
Item
cells/kg)
boolean
Item Group
C0680251 (UMLS CUI)
Communicable Disease
Item
active infection
boolean
C0009450 (UMLS CUI [1])
Pregnancy
Item
pregnant woman are excluded from the study
boolean
C0032961 (UMLS CUI [1])
Contraceptive methods Lacking
Item
subjects not using contraceptives are excluded from the study
boolean
C0700589 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
Absolute neutrophil count | Platelet Count measurement
Item
anc ≤ 1,500/μl and/or platelet count ≤ 100,000/μl
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
Life Expectancy
Item
life expectancy of ≤ 2 months
boolean
C0023671 (UMLS CUI [1])
Radioimmunotherapy Against B cells | Zevalin | Bexxar | Monoclonal Antibody Therapy Against B cells allowed | Rituximab allowed | Epratuzumab allowed
Item
prior anti-b-cell radioimmunotherapy (e.g., zevalin or bexxar) [patients who have received prior anti-b-cell monoclonal antibody therapy (e.g., rituximab or epratuzumab) will not be excluded.]
boolean
C0085101 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C0004561 (UMLS CUI [1,3])
C0919274 (UMLS CUI [2])
C0919272 (UMLS CUI [3])
C0279694 (UMLS CUI [4,1])
C0521124 (UMLS CUI [4,2])
C0004561 (UMLS CUI [4,3])
C0683607 (UMLS CUI [4,4])
C0393022 (UMLS CUI [5,1])
C0683607 (UMLS CUI [5,2])
C1120776 (UMLS CUI [6,1])
C0683607 (UMLS CUI [6,2])
Total body radiation therapy
Item
prior total body radiation therapy
boolean
C0948732 (UMLS CUI [1])
Human anti-mouse antibody test Positive
Item
positive human anti-mouse antibody (hama) testing
boolean
C1868744 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial